WHO Policies and Guidelines

• Use of TB IGRAs in low- and middle-income countries, 2011 (PDF)
• Commercial Serodiagnostic Tests for Diagnosis of Tuberculosis, 2011 (PDF)
• Automated real- time NAAT for Tuberculosis and Rifampicin Resistance, 2011 (PDF)
• WHO roadmap for Xpert MTB/RIF for rapid diagnosis of TB and MDR-TB, December 2010 Download Roadmap (PDF)
• WHO Framework for Implementing New Tuberculosis Diagnosis, July 2010
  Download Framework (PDF)
• Same-Day-Diagnosis of Tuberculosis by Microscopy, July 2010
  Download Policy Statement (PDF)
• Fluorescent Light Emitting Diode (LED) Microscopy for Diagnosis of Tuberculosis, July 2010
  Download Policy Statement (PDF)
• Non-Commercial Culture and Drug-Susceptibility Testing Methods for Screening of Patients at Risk of Multi-drug Resistant Tuberculosis, June 2010
  Download Policy Statement (PDF)
• Molecular Line Probe Assays for Rapid Screening of Patients at Risk of Multidrug-Resistant Tuberculosis, June 2008
  Download Policy Statement (PDF)
• Policy guidance on drug-susceptibility testing (DST) of second-line antituberculosis drugs, 2008
  Download Policy Statement (PDF)
• Policy on liquid medium for culture and DST, 2007
• Definition of a new sputum smear-positive TB case, 2007
• Reduction of number of smears for the diagnosis of pulmonary TB, 2007